PAUL STEVEN M
SEC Form 4 insider trading activity
PAUL STEVEN M has filed 3 SEC Form 4 filings (4 transaction rows) across 2 companies, including RAPP, SPTX, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Oct 22, 2026.
On the most recent filing, PAUL STEVEN M is listed as Director at Rapport Therapeutics, Inc. Inside the rolling window, PAUL STEVEN M reported 1 open-market purchase totaling $974K in RAPP and no open-market sales.
Companies traded
Other insiders at RAPP
Insider Buying
$974K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
2
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has PAUL STEVEN M made?
PAUL STEVEN M has filed 3 SEC Form 4 filings (4 transaction rows) across 2 companies, including RAPP, SPTX since 2025.
Which companies does PAUL STEVEN M trade?
PAUL STEVEN M has filed SEC Form 4 disclosures for 2 companies, including RAPP, SPTX.
When was PAUL STEVEN M's most recent SEC Form 4 filing?
PAUL STEVEN M's most recent SEC Form 4 filing on Tracefour is dated Oct 22, 2026.
What is PAUL STEVEN M's total buy and sell value in the current window?
Inside the rolling retention window, PAUL STEVEN M bought $974K and sold $0 based on SEC Form 4 filings.
What was PAUL STEVEN M's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 35,714 RAPP shares on 2026-10-22, worth $974K, per SEC Form 4 filings.